Combined Shareholders’ Meeting of 24 May 2022 - Global
Skip to main content
Combined Shareholders’ Meeting of 24 May 2022
Press shift tab to select search category
Loading...
  • Newsroom  arrow down
    < Back
    • Press Releases
    • Media Updates
    • Media Library
    • Contacts
    • Subscribe

    • Our 2023 Integrated Annual Report is live!

       Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Accounts
    • Investor Events
    • Financial Calendar
    • Corporate News
    • Regulated Information
    • Shareholder Information
    • Contacts
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Locations
    • Adverse Event Reporting
    • Subscribe
  • Press shift tab to select search category
    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
        < Back
      • Science
      • Oncology
      • Rare Disease
      • Neuroscience
    • Profiles
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Partnering
        < Back
      • Partnering
      • Therapeutic focus
      • Meet the team
    • Pipeline
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Press Releases
  3. Regulated Information press releases

Combined Shareholders’ Meeting of 24 May 2022

Post navigation

Previous
Next

Combined Shareholders’ Meeting of 24 May 2022

Combined Shareholders’ Meeting of 24 May 2022

- 03 May 2022 - 0 mins read

Post navigation

Previous
Next
Share this on social media
  • Share on LinkedIn
  • Share on Facebook

Related Press Releases

30 August 2024 1 mins read

Testing video 1
30 August 2024 1 mins read

Testing video 3
30 August 2024 1 mins read

Testing video 2
Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio
02 March 2023 9 mins read

Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio
Combined Shareholders’ Meeting of 30 May 2018
30 May 2018 0 mins read

Combined Shareholders’ Meeting of 30 May 2018

IPN price

€121.50

 €0.40 (0.33%)

  • Adverse Event Reporting
  • Annual Report
  • Locations
  • Contacts
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Contacts
  • Terms & Conditions
  • Cookie Policy
  • Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website.
To continue, please click on Continue?

Continue
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.